Status:
WITHDRAWN
Collective Accuryn Physiologic Signals and Signatures
Lead Sponsor:
Potrero Medical
Conditions:
Critical Illness
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
The CAPSS Study is a retrospective and prospective, multi-center, single-arm post-market data collection study with an FDA cleared device. Physiologic data measurements will be collected from enrolled...
Detailed Description
The primary objective of the CAPSS Study is to track and analyze changes in physiologic data streams to identify clinical signatures that may enable earlier diagnosis of, and effective intervention in...
Eligibility Criteria
Inclusion
- Received Accuryn Monitoring System during hospital stay.
- Diagnosed with or developed one or more of the targeted conditions while connected to the Accuryn Monitoring System.
Exclusion
- 1\. In the opinion of the investigator, the patient is unsuitable for the study.
Key Trial Info
Start Date :
March 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 29 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03817281
Start Date
March 29 2020
End Date
March 29 2020
Last Update
January 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington Harborview Medical Center
Seattle, Washington, United States, 98104